<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03125733</url>
  </required_header>
  <id_info>
    <org_study_id>STESD for Zenker</org_study_id>
    <nct_id>NCT03125733</nct_id>
  </id_info>
  <brief_title>A New Treatment for Zenker's Diverticulum-submucosal Tunneling Endoscopic Septum Division</brief_title>
  <acronym>STESD</acronym>
  <official_title>A Prospective International Multicenter Study on the Efficacy and Safety of Submucosal Tunneling Endoscopic Septum Division (STESD) for the Treatment of Zenker's Diverticulum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Winthrop University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Zenker's Diverticulum (ZD) is a sac-like outpouching of the lining of the esophageal wall at&#xD;
      the upper esophagus. It is a rare disease typically seen in the middle-aged and older adults.&#xD;
      Common symptoms of the disease include difficulties in swallowing (dysphagia), food reflux&#xD;
      (regurgitation), unpleasant breath smells (halitosis) and couch, choking and hoarseness etc.&#xD;
      (respiratory complications). Pills lodging in the sac and thus unable to take effect is also&#xD;
      a common and yet often overlooked problem.&#xD;
&#xD;
      Traditional treatment for ZD included open resection done by head and neck surgeons and&#xD;
      direct septum division done by ENT doctors. Septum division done by endoscopists is a new&#xD;
      modality of treatment and so far has used the same approach as the ENT doctors-the wall&#xD;
      between the sac and the normal esophageal lumen (the septum) is cut down directly so that&#xD;
      food will not be held in the sac.&#xD;
&#xD;
      A cutting-edge endoscopic treatment for ZD is now emerging. In this approach, what we call&#xD;
      submucosal tunneling endoscopic septum division (STESD), the wall is not cut directly, but&#xD;
      inside a tunnel created by lifting the wallpaper (the mucosa lining the esophageal wall).&#xD;
      After the muscle septum is completely cut, the mucosa is then sealed by clips, restoring&#xD;
      integrity of the esophageal lining.&#xD;
&#xD;
      The advantage of STESD is twofold. First, the esophageal mucosa will be sealed after the&#xD;
      operation, so that the chance of extravasation of luminal content with its relevant&#xD;
      complications will be smaller. Second, under the protection of the tunnel, the endoscopist&#xD;
      will be able to cut the septum completely down to its bottom, ensuring a more satisfactory&#xD;
      symptom resolution. In short, our hypothesis is that treating Zenker's diverticulum by the&#xD;
      tunneling endoscopic technique should be both safer and more effective than traditional&#xD;
      methods.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with symptomatic Zenker's diverticulum are considered for STESD. The diagnosis is&#xD;
      based on clinical presentation, barium swallow, EGD and a swallow test to rule out other&#xD;
      possible disorders causing cervical dysphagia. A scoring system (Costamagna, GIE, 2016) is&#xD;
      used to evaluate severity of the symptoms. Four symptoms are evaluated: 1) dysphagia, 2)&#xD;
      regurgitation, 3) daytime respiratory symptoms and 4) nighttime respiratory symptoms. These&#xD;
      are scored based on a solid food diet according to the symptom frequency calculated within 2&#xD;
      consecutive weeks: 0-never, 1-1day/ week, 2-2~4days/ week, 3-≥5 days/ week. Under EGD and&#xD;
      barium swallow test, configuration of the diverticulum is documented in detail (Shou-Jiang&#xD;
      Tang, Laryngoscope, 2008). Quality of life is assessed using the SF-36 form. The pre- and&#xD;
      post-STESD symptom score, quality of life score, and diverticulum configuration are compared.&#xD;
&#xD;
      Adverse events are recorded and graded according to the system suggested by the ASGE workshop&#xD;
      (Cotton, GIE, 2010).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Anticipated">June 14, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 14, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Short-term change of symptom score</measure>
    <time_frame>1 months after STESD</time_frame>
    <description>Symptoms for Zenker's diverticulum are scored at follow-up visits and compared with pre-STESD value</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peri-operative adverse events</measure>
    <time_frame>start of STESD to 30 days post-op</time_frame>
    <description>Details and grading for any adverse event as defined by the ASGE lexicon are recorded during the peri-operative period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mid-term change of symptom score</measure>
    <time_frame>12 months after STESD</time_frame>
    <description>Symptoms for Zenker's diverticulum are evaluated at follow-up visit and compared to pre-STESD value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of diverticulum size under EGD</measure>
    <time_frame>1 months after STESD</time_frame>
    <description>ESD is done at follow-up visit and configuration of the diverticulum is compared to that pre-STESD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of diverticulum size under esophagram</measure>
    <time_frame>1 months after STESD</time_frame>
    <description>Barium esophagram is done at follow-up visit and configuration of the diverticulum is compared to that pre-STESD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Call for other treatments, such as repeat myotomy</measure>
    <time_frame>12 months after STESD</time_frame>
    <description>Call for any additional treatment for Zenker's diverticulum is recorded at follow-up visits</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes in quality of life score</measure>
    <time_frame>Baseline and 12 months after STESD</time_frame>
    <description>Patients' quality of life is recorded by using the SF-36 system</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Zenker Diverticulum</condition>
  <arm_group>
    <arm_group_label>STESD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Submucosal tunneling endoscopic septum division</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Submucosal tunneling endoscopic septum division</intervention_name>
    <description>STESD includes 4 steps:&#xD;
Mucosal incision: submucosal injection of normal saline-indigo carmine solution is performed 2-3cm proximal to the diverticular septum and a 1.5-2cm longitudinal mucosal incision is made using the endoscopic knife.&#xD;
Submucosal tunneling: a submucosal tunnel is created using the same technique as applied by Peroral Endoscopic Myotomy (POEM) at both sides of the septum until 1-2cm distal to the bottom of the diverticulum.&#xD;
Septum Division: cricopharyngeal myotomy is performed longitudinally along the mid-line of the septum and ends in the normal esophageal muscle.&#xD;
Mucosal Closure: the mucosa incision, as well as any accidental mucosotomy if present, is closed with hemostatic clips.</description>
    <arm_group_label>STESD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of Zenker's diverticulum by symptoms, esophagram and/ or EGD&#xD;
&#xD;
          -  Symptomatic score≥2 in any of the symptoms or ≥3 in total&#xD;
&#xD;
          -  Patients or legal surrogates willing and competent to give informed consent and to&#xD;
             comply with follow up visits and tests&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with minimal symptoms (score ≤1 in all four symptoms and &lt;3 in total)&#xD;
&#xD;
          -  Presence of coagulopathy or pregnancy&#xD;
&#xD;
          -  Patients who, in the investigator's opinion, are medically unstable or have a life&#xD;
             expectancy of&lt; 2 years, are unable to give informed consent or have poor compliance&#xD;
             with follow-up, or whose risks of participating in the study outweigh the benefits&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ping-Hong Zhou, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Zhongshan Hospital, Fudan University, Shanghai, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stavros N Stavropoulos, MD</last_name>
    <role>Study Director</role>
    <affiliation>NYU Winthrop Hospital, Mineola, NY, USA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Quan-Lin Li, MD</last_name>
    <phone>+86-021-64041990</phone>
    <email>liquanlin321@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiao-Cen Zhang, MD</last_name>
    <phone>+86-15000448731</phone>
    <email>xcezhang@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NYU Winthrop Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Kollarus, RN</last_name>
      <phone>516-663-4652</phone>
      <email>maria.kollarus@nyulangone.org</email>
    </contact>
    <contact_backup>
      <last_name>Wilmide Maignan</last_name>
      <phone>+1(516)663-4623</phone>
      <email>WMaignan@nyuwinthrop.org</email>
    </contact_backup>
    <investigator>
      <last_name>Stavros N Stavropoulos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rani Modayil, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongshan Hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Quan-Lin Li, MD</last_name>
      <phone>+85-021-64041990</phone>
      <email>liquanlin321@126.com</email>
    </contact>
    <investigator>
      <last_name>Ping-Hong Zhou, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Quan-Lin Li, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Costamagna G, Iacopini F, Bizzotto A, Familiari P, Tringali A, Perri V, Bella A. Prognostic variables for the clinical success of flexible endoscopic septotomy of Zenker's diverticulum. Gastrointest Endosc. 2016 Apr;83(4):765-73. doi: 10.1016/j.gie.2015.08.044. Epub 2015 Sep 3.</citation>
    <PMID>26344886</PMID>
  </reference>
  <reference>
    <citation>Tang SJ, Jazrawi SF, Chen E, Tang L, Myers LL. Flexible endoscopic clip-assisted Zenker's diverticulotomy: the first case series (with videos). Laryngoscope. 2008 Jul;118(7):1199-205. doi: 10.1097/MLG.0b013e31816e2eee.</citation>
    <PMID>18401278</PMID>
  </reference>
  <reference>
    <citation>Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A Jr, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010 Mar;71(3):446-54. doi: 10.1016/j.gie.2009.10.027.</citation>
    <PMID>20189503</PMID>
  </reference>
  <reference>
    <citation>Gutschow CA, Hamoir M, Rombaux P, Otte JB, Goncette L, Collard JM. Management of pharyngoesophageal (Zenker's) diverticulum: which technique? Ann Thorac Surg. 2002 Nov;74(5):1677-82; discussion 1682-3.</citation>
    <PMID>12440629</PMID>
  </reference>
  <reference>
    <citation>Ferreira LE, Simmons DT, Baron TH. Zenker's diverticula: pathophysiology, clinical presentation, and flexible endoscopic management. Dis Esophagus. 2008;21(1):1-8. doi: 10.1111/j.1442-2050.2007.00795.x. Review.</citation>
    <PMID>18197932</PMID>
  </reference>
  <reference>
    <citation>Law R, Katzka DA, Baron TH. Zenker's Diverticulum. Clin Gastroenterol Hepatol. 2014 Nov;12(11):1773-82; quiz e111-2. doi: 10.1016/j.cgh.2013.09.016. Epub 2013 Sep 18. Review.</citation>
    <PMID>24055983</PMID>
  </reference>
  <reference>
    <citation>Li QL, Chen WF, Zhang XC, Cai MY, Zhang YQ, Hu JW, He MJ, Yao LQ, Zhou PH, Xu MD. Submucosal Tunneling Endoscopic Septum Division: A Novel Technique for Treating Zenker's Diverticulum. Gastroenterology. 2016 Dec;151(6):1071-1074. doi: 10.1053/j.gastro.2016.08.064. Epub 2016 Sep 21.</citation>
    <PMID>27664512</PMID>
  </reference>
  <reference>
    <citation>Vigneswaran Y, Tanaka R, Gitelis M, Carbray J, Ujiki MB. Quality of life assessment after peroral endoscopic myotomy. Surg Endosc. 2015 May;29(5):1198-202. doi: 10.1007/s00464-014-3793-2. Epub 2014 Sep 24.</citation>
    <PMID>25249144</PMID>
  </reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>April 16, 2017</study_first_submitted>
  <study_first_submitted_qc>April 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2017</study_first_posted>
  <last_update_submitted>August 2, 2018</last_update_submitted>
  <last_update_submitted_qc>August 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endoscopy, Digestive system</keyword>
  <keyword>Natural orifice transluminal endoscopic surgery</keyword>
  <keyword>Therapeutic</keyword>
  <keyword>Complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diverticulum</mesh_term>
    <mesh_term>Diverticular Diseases</mesh_term>
    <mesh_term>Zenker Diverticulum</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

